Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 04/01/24
Due: 04/01/25
Phase: N/A
Priority: Normal
Start: 08/25/20
End: 07/30/23
Due: 07/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment of an Inherited Ventricular Arrhythmia | NCT05122975 | Armgo Pharma, Inc. | user2@example.com | None | 2023-08-01 | 2024-04-01 | 2025-04-01 | - | - | 2025-07-14 |
| S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM) | NCT04141670 | Armgo Pharma, Inc. | user2@example.com | None | 2020-08-25 | 2023-07-30 | 2024-07-30 | - | - | 2025-07-14 |